In vitro activity on Cryptosporidium parvum oocyst of different drugs with recognized anticryptosporidial efficacy

Revue de Medecine Veterinaire

Volumn 155, Issue 8-9, 2004, Pages 453-456

  Castro Hermida, J A ^a,b   Pors, I ^a   Ares Mazas, E ^b   Chartier, C ^a  

^a Healthy Pigs Production and Experimentation Section   (France)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Anticryptosporidial drug; Cryptosporidium parvum; Cyclodextrins; In vitro activity; Oocyst

Indexed keywords

ALPHA CYCLODEXTRIN; ANTIPARASITIC AGENT; AZITHROMYCIN; BETA CYCLODEXTRIN; HALOCUR; HALOFUGINONE LACTATE; NITAZOXANIDE; NODIK; PAROMOMYCIN; TOLTRAZURIL;

ANTIMICROBIAL ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYPTOSPORIDIUM PARVUM; DRUG EFFICACY; NONHUMAN; OOCYST;

ANIMALIA; CRYPTOSPORIDIUM; CRYPTOSPORIDIUM PARVUM;

EID: 8444252217     PISSN: 00351555     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. AMADI B., MWIYA M., MUSUKU J., WATUKA A., SIANONGO S., AYOUB A., KELLY P. : Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet, 2002, 360, 1375-1380.
2. CAMPBELL A.T., ROBERTSON L.J., SMITH H.V. : Viability of Cryptosporidium parvum oocysts: correlation of in vitro excystation with inclusion or exclusion of fluorogenic vital dyes. Appl. Environ. Microbiol., 1992, 58, 3488-3493.
3. CASTRO-HERMIDA J.A., FREIRE-SANTOS F., OTEIZA-LOPEZ A.M., VERGARA-CASTIBLANCO C.A., ARES-MAZAS M.E. : In vitro and in vivo efficacy of lasalocid for treatment of experimental cryptosporidiosis. Vet. Parasitol., 2000, 90, 265-270.
4. CASTRO-HERMIDA J.A., GONZALEZ-LOSADA Y., FREIRE-SANTOS F., MEZO-MENENDEZ M., ARES-MAZAS M.E. : Evaluation of β-cyclodextrin against natural infections of cryptosporidiosis in calves. Vet. Parasitol., 2001, 101, 85-89
5. CASTRO-HERMIDA J.A., QUILEZ-CINCA J., LOPEZ-BERNAD F., SANCHEZ-ACEDO C., FREIRE-SANTOS F., ARES-MAZAS M.E. : Treatment with β-cyclodextrin of natural Cryptosporidium parvum infections in lambs under field conditions. Int. J. Parasitol., 2001, 31, 1134-1137.
6. CASTRO-HERMIDA J.A., ARES-MAZAS M.E. : In vitro and in vivo efficacy of α-cyclodextrin for treatment of experimental cryptosporidiosis. Vet. Parasitol., 2003, 114, 237-245.
7. CHARTIER C., MALLEREAU M.P., NACIRI M. : Prophylaxis using paromomycin of natural cryptosporidial infection in neonatal kids. Prev. Vet. Med., 1996, 25, 357-361.
8. CHARTIER C., MALLEREAU M.P., LENFANT D. : Efficacité du lactate d'halofuginone dans la prévention de la cryptosporidiose chez le chevreau nouveau-né. Rev. Méd. Vét., 1999, 150, 341-346.
9. CHEN X.M., KEITHLY J.S., PAYA C.V., LARUSSO N.F. : Cryptosporidiosis. N. Engl. J. Med., 2002, 346, 1723-1731.
10. COOMBS G.H., MULLER S. : Recent advances in the search for new anti-coccidial drugs. Int. J. Parasitol., 2002, 32, 497-508.
11. DE GRAAF D.C., VANOPDENBOSCH E., ORTEGA-MORA L.M., ABBASSI H., PEETERS J.E. : A review of the importance of cryptosporidiosis in farm animals. Int. J. Parasitol., 1999, 29, 1269-1287.
12. GILLES H.M., HOFFMAN P.S. : Treatment of intestinal parasitic infections: a review of nitazoxanide. Trends Parasitol., 2002, 18, 95-97.
13. GRINBERG A., MARKOVICS A., GALINDEZ J., LOPEZ-VILLALOBOS N., KOSAK A., TRANQUILLO V.M. : Controlling the onset of natural cryptosporidiosis in calves with paromomycin sulphate. Vet. Rec., 2002, 151, 606-608.
14. HORAN P.K., KAPPLER J.W. : Automated fluorescence analysis for cytotoxicity assays. J. Immunol., 1977, 18, 309-316.
15. IRIE T., UEKAMA K. : Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev., 1999, 36, 101-123.
16. KADAPPU K.K., NAGARAJA M.V., RAO P.V., SHASTRY B.A. : Azithromycin as treatment for cryptosporidiosis in human immunodeficiency virus disease. J. Postgrad. Med., 2002, 48, 179-181.
17. KAYSER O., KIDERLEN A.F. : Delivery strategies for antiparasitics. Expert. Opin. Investig. Drugs, 2003, 12, 1-11.
18. LEFAY D., NACIRI M., POIRIER P., CHERMETTE R. : Efficacy of halofuginone lactate in the prevention of cryptosporidiosis in suckling calves. Vet. Rec., 2001, 148, 108-112.
19. LI X., BRASSEUR P., AGNAMEY P., LEMETEIL D., FAVENNEC L., BALLET J.J., ROSSIGNOL J.F. : Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model. Folia Parasitol., 2003, 50, 19-22.
20. LOFTSSON T., BREWSTER M.E. : Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci., 1996, 85, 1017-1025.
21. LORENZO M.J., ARES-MAZAS M.E., VILLACORTA I., DURAN D. : Effect of ultraviolet disinfection of drinking water on the viability of Cryptosporidium parvum oocysts. J. Parasitol., 1993, 79, 67-70.
22. MANCASSOLA R., REPERANT J.M., NACIRI M., CHARTIER C. : Chemoprophylaxis of Cryptosporidium parvum infection with paromomycin in kids and immunological study. Antimicrob. Agents Chemother., 1995, 39, 75-78.
23. NACIRI M., YVORE P. : Efficacité du lactate d'halofuginone dans le traitement de la cryptosporidiose chez l'agneau. Rec. Méd. Vét., 1989, 165, 823-826.
24. NACIRI M., MANCASSOLA R., YVORE P., PEETERS J.E. : The effect of halofuginone lactate on experimental Cryptosporidium parvum infections in calves. Vet. Parasitol., 1993, 45, 199-207.
25. RAJEWSKI R.A., STELLA V.J. : Pharmaceutical application of cyclodextrins. 2. In vivo drug delivery. J. Pharm. Sci., 1996, 85, 1142-1169.
26. REHG J.E. : Activity of azithromycin against cryptosporidia in immunosupprised rats. J. Infect. Dis., 1991, 163, 1293-1296.
27. REHG J.E. : Anticryptosporidial activity of lasalocid and other ionophorous antibiotics in immunosuppressed rats. J. Infect. Dis., 1993, 168, 1566-1569.
28. SRETER T., SZELL Z., VARGA I. : Attempted chemoprophylaxis of cryptosporidiosis in chickens, using diclazuril, toltrazuril or Garlic extract. J. Parasitol., 1999, 85, 989-991.
29. TRAD O., JUMAA P., UDUMAN S., NAWAZ A. : Eradication of Cryptosporidium in four children with acute lymphoblastic leukaemia. J. Trop. Pediatr., 2003, 49, 128-130.
30. TZIPORI S. : Cryptosporidiosis : laboratory investigations and chemotherapy. In : BAKER J.R., MULLER R., ROLLINSON D. (éd.) : Advances in Parasitology, Opportunistic Protizoan in Humans, London, 1998, pp 188-212.
31. VERGARA CASTIBLANCO C.A. : Estudio inmunologico de la cryptosporidiosis humana en Colombia. Thesis, Universidad de Santiago de Compostela, Spain, 1999.
32. VILLACORTA I., PEETERS J.E., VANOPDENBOSH E., ARESMAZAS M.E., THEYS H. : Efficacy of halofuginone lactate against Cryptosporidium parvum in calves. Antimicrob. Agents Chemother., 1991, 35, 283-287.
33. VIU M., QUILEZ J., SANCHEZ-ACEDO C., DEL CACHO E., LOPEZ-BERNARD F. : Field trial on the therapeutic efficacy of paromomycin on natural Cryptosporidium parvum infections in lambs. Vet. Parasitol., 2000, 90, 163-170.
34. WOODS K.M., NESTERENKO M.V., UPTON S.J. : Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro. Ann. Trop. Med. Parasitol., 1996, 90, 603-615.
35. XIAO L., MORGAN U.M., FAYER R., THOMPSON R.C.A., LAL A.A. : Cryptosporidium systematics and implications for public health. Parasitol. Today, 2002, 26, 287-29